Registration Closing for the Cell & Gene Therapy Congress and 2nd Annual Stem Cell Congress 2015

Registration is closing shortly for the Cell & Gene Therapy Congress and 2nd Annual Stem Congress, taking place on the 9th and 10th November 2015 in London.

 

We will look at the development of cell therapies, as well as clinical trial case studies and strategies for commercialisation of successful treatments. The latest developments in the use of gene-editing tools will be one of the highlights of the discussions, as well as looking at case studies of positive clinical data. Hot topics will include approaches to producing innovative gene delivery mechanisms including transposon technology, as well as cutting edge technologies and solutions for manufacture of raw materials.

 

Experts from academia, pharmaceutical and biotech organisations will present on the key topics in the industry today, ranging from novel reprogramming and transdifferentiation techniques, to the most effective methods to engineer mammalian stem cells or ensure controlled growth. We will address the major issues and opportunities in the field of stem cell therapies, including up to date clinical trial information and approaches to commercialisation.

 

Secure your place today to have access to the following streams:

- Cell & Gene Therapy: Development, Clinical Trials & Commercialisation

- Cell Therapy Bioprocessing

- Stem Cell & iPSC Bioprocessing and Manufacturing

- Stem Cell Therapy inc. Clinical & Commercialisation

 

To review the full agenda, please visit: http://www.stemcells-congress.com/download-agenda-marketing/

 

Our dedicated research into the field ensures that we secure the very best quality speakers from top pharma companies and academic institutes to share their inspirational work with the conference attendees. We have ensured that every speaker has a unique story to bring to the audience and that they will present the latest, most exciting work – highlighting any pitfalls they have made along the way.

 

2015 speakers include:

 >> Robert Hariri, Founder, Chairman & CSO, Celgene

 >> Sicco Popma, Scientific Director, Stem Cells Research, Janssen

 >> Gwen Binder-Scholl, Executive VP, Adaptimmune

 >> Gabor Veres, Vice President Pre-Clinical Research, Bluebird Bio

 >> John Harrington, Chief Scientific Officer, Athersys

 >> Stewart Abbot, Vice President Translational Research, Fate Therapeutics

 >> Jasmin Kee, Head of Engineering, ReNeuron

 >> Roger Grau, Fellow, Cell Therapy, Novartis

 

Attending this Congress will give you:

 >> Full access to the 2 days of conference presentations

 >> Free access to the 4th Annual Cell Culture & Bioprocessing Congress

 >> Lunch and Refreshments during the congress

 >> Access to all networking activities

 >> Access to exhibition area

 >> Conference workbook and online access to conference materials, notes and presentations

 

Download the conference programme to find out more about this two day congress: http://www.celltherapy-congress.com/download-agenda-marketing/

 

Reserve Your Place Today!

Registration is closing shortly with only a limited number of places available. If you’re looking to present a poster, we have limited spaces available on a strictly first come first served basis. For further information regarding our poster presentations, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call us on +44(0)1865 248455.

 

You can also discover even more and discuss the latest methods in cell line engineering and advances in cell culture development on our social media: LinkedIn: Stem Cell Networking Group Twitter: https://twitter.com/CellCultureConf

 

Follow: @CellCultureConf and join the Congress conversation on #StemCell15 and #GeneTherapy15